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UPR in palmitate-treated pancreatic beta-cells is
not affected by altering oxidation of the fatty acid
Ernest Sargsyan*, E-ri Maria Sol and Peter Bergsten
Abstract
Background: Elevated levels of lipids are detrimental for beta-cell function and mass. One of the mechanisms of
how fatty acids induce apoptosis is development of the unfolded protein response (UPR). It is still far from
understood how fatty acids activate the UPR, however.
Methods: We examined how palmitate-induced activation of the UPR was affected by altering the metabolism of
the fatty acid in insulin-secreting INS-1E and MIN6 cell lines and intact human islets. To increase oxidation, we used
low glucose (5.5 mM) or AICAR; and to reduce oxidation, we used high glucose (25 mM) or etomoxir. UPR was
measured after 3, 24 and 48 hours of palmitate treatment.
Results: Modulation of palmitate oxidation by either glucose or the pharmacological agents did not affect
palmitate-induced UPR activation.
Conclusion: Our finding suggests that other factors than oxidation of palmitate play a role in the activation of UPR
in fatty acid-treated beta-cells.
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Introduction
Extended elevated levels of fatty acids impair glucose-
stimulated insulin secretion (GSIS) and induce apoptosis
in insulin-secreting beta-cells [1,2]. Various mechanisms
of fatty-induced beta-cell apoptosis have been proposed,
where development of the unfolded protein response
(UPR) has been studied intensely during recent times
[3-11]. The UPR or the endoplasmic reticulum (ER)
stress response is the adaptive cellular reactions that
coordinate down-regulation of overall protein synthesis
and increased protein folding capacity by up-regulation
of molecular chaperones and enhanced protein degrada-
tion [12-15]. Three signaling pathways of UPR, controlled
by ER transmembrane proteins PKR-like endoplasmic
reticulum kinase (PERK), IRE1 and activating transcrip-
tion factor (ATF) 6, have been discovered [14]. Under
normal conditions, these proteins are inactive due to
interaction with molecular chaperone BiP. Accumulation
of unfolded proteins leads to dissociation of BiP and acti-
vation of these sensors. Activation of PERK occurs early
in time and leads to phosphorylation of eukaryotic initia-
tion factor 2a (eIF2a), which attenuates protein synthesis
and, at the same time, stimulates translation of ATF4.
ATF4 is a transcription factor that regulates expression
of molecular chaperones. IRE1, after activation, catalyzes
splicing of XBP1. Spliced form of XBP1 encodes an active
transcription factor that regulates expression of molecu-
lar chaperones and also proteins involved in degradation
and secretion. Activation of ATF6 leads to its transloca-
tion to Golgi, where after cleavage with proteases it
forms an active transcription factor that controls expres-
sion of molecular chaperones. When these mechanisms
cannot compensate for the ER stress, cell death pathways
are activated. The C/EBP-homologous protein/growth
arrest and DNA damage-inducible protein (CHOP/
GADD153) transcription factor and JNK have been
implicated in this aspect of the UPR [16]. Proposed
mechanisms of how fatty acids induce ER stress include
ER Ca2+ release, overload of ER with unfolded proteins
and accumulation of tripalmitin in the ER [17,18]. In the
present study, we examined the role of palmitate metabo-
lism in the fatty acid-triggered activation of UPR in insu-
lin-secreting cell lines INS-1E and MIN6 and intact
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human islets. It is known that reduced oxidation of
palmitate directs long chain CoA towards non-oxidative
metabolic pathways, such as generation of TAGs and cer-
amides [19,20]. Palmitate oxidation was modified by
using various concentrations of glucose. According to the
malonyl-CoA hypothesis high glucose reduces fatty acid
oxidation, which is due to inhibition of fatty acid trans-
porter CPT1 by increased production of malonyl-CoA
[19,20]. At low glucose, beta-cells oxidize fatty acids [21].
Additionally, we used AMPK agonist AICAR, which
favors fatty acid oxidation and prevents lipotoxicity, and
CPT1 inhibitor etomoxir that reduces fatty acid oxidation
and aggravates lipotoxicity [19,22,23].
Materials and methods
Cell culture
Rat INS-1E cells (a kind gift from Dr. Pierre Maechler,
Geneva University) were cultivated in RPMI 1640 med-
ium containing 11 mM glucose and supplemented with
10% fetal bovine serum (FBS), 2 mM L-glutamine,
1 mM sodium pyruvate, 10 mM HEPES and 55 μM b-
mercaptoethanol at 37°C and 5% CO2. All reagents
were purchased from Invitrogen (Carlsbad, CA). Experi-
ments with INS-1E cells were performed between pas-
sages 65 and 90. Mouse insulinoma MIN6 cells (a kind
gift from Prof. Jun-Ichi Miyazaki, Osaka University)
were maintained in Dulbecco’s Modified Eagle medium
(DMEM) containing 25 mM glucose and supplemented
with 10% FBS and 55 μM b-mercaptoethanol at 37°C
and 5% CO2. All experiments with MIN6 cells were
performed between passages 21 and 28. Human islets
were obtained from the Islet Transplantation Unit at
Uppsala University from non-diabetic individuals.
Human islets were cultured in CMRL 1066 medium
containing 5.5 mM glucose and supplemented with 10%
FBS.
Ethics Statement
Ethical permission to use human islets isolated from
healthy individuals have been obtained from the Regional
Ethical Review Board in Uppsala (date: 2010-02-10; num-
ber 2010/006).
Free fatty acid preparation and cell/islet treatment
Culture medium containing palmitate (Sigma, St. Louis,
MO) was prepared as previously described [4,10]. Briefly,
the fatty acid was dissolved in 50% ethanol to a concentra-
tion of 100 mM. This stock solution was diluted in culture
medium to a required concentration and then allowed to
complex with 0.5% fatty acid free BSA (Boehringer Man-
nheim GmbH, Mannheim, Germany) for 30 min at 37°C.
Cells cultured to 65-70% confluence or ~50 human islets
were exposed to palmitate in the presence of different
concentrations of glucose for 48 hours. Whereas FBS was
maintained during palmitate exposure of INS-1E and
MIN6 cells [10,11], FBS was removed during palmitate
incubation of human islets [24]. Cells and islets cultured
in the presence of palmitate were also treated with 1 mM
AICAR or 0.2 mM etomoxir (both purchased from
Sigma).
Measurements of palmitate oxidation rate
Cells/islets were cultured in media containing 0.5 mM
palmitate and 2 μCi [3H]palmitate per ml. To measure
oxidation, media samples were collected after culture
and 3H2O separated from [
3H]palmitate using Folch
extraction [25]. The volume of 10 ml Ultima Gold™
scintillation fluid (Chemical Instruments AB, Sollentuna,
Sweden) was added to 500 μl 3H2O and radioactivity
determined by a liquid-scintillation spectrometer (Wal-
lac System 1400™ PerkinElmer, Boston, MA). The
results were normalized to DNA content.
Protein measurements by Western blot analysis
Details of the procedure for immunoblotting have been
described previously [26]. Immunoblot analyses were
performed with antibodies towards phosphorylated
PERK (p-PERK), phosphorylated eIF2a (p-eIF2a) (Cell
Signaling, Beverly, MA), CHOP/GADD153 (Santa Cruz
Biotechnology, Santa Cruz, CA) and BiP/GRP78
(Abcam, Cambridge, UK) [27]. Immuno-reactive bands
were visualized with Fluor-S MultiImager MAX (BioRad,
Hercules, CA) and quantified with Quantity One soft-
ware (Bio-Rad).
Analysis of mRNA expression by real-time PCR
Total mRNA was isolated from the cells by Trizol (Invi-
trogen) and reversely transcribed with SuperScript™ III
First-Strand Synthesis System for RT-PCR (Invitrogen).
The real-time PCR was performed in 10 μl volume con-
taining ~20 ng cDNA, 0.5 μM forward and reverse pri-
mers and 5 μl Dynamo Capillary SYBR Green qPCR kit
(Finnzymes, Espoo, Finland). Primers used for the
amplification are shown in Table 1. PCR products were
quantified fluorometrically using SYBR Green and nor-
malized to the housekeeping gene b-actin and relative
to the control (11 mM glucose). The following formula
was used: target amount = 2-ΔΔCt, where ΔΔCt = {[Ct
(target gene sample) - Ct (b-actin sample)] - [Ct (control
sample) - Ct (b-actin control)} [28].
Statistical analysis
Results are presented as means ± SEM. Statistical signif-
icance between two conditions was analyzed using one-
way ANOVA with Tukey post-hoc test. P < 0.05 was
considered statistically significant.
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Results
Palmitate oxidation is reduced by high glucose in human
islets, MIN6 cells and INS-1E cells
Palmitate oxidation was measured in palmitate-exposed
human islets, MIN6 and INS-1E cells cultured at 5.5
(low) or 25 (high) mM glucose for 3, 24 or 48 hours. In
human islets (Figure 1A) and MIN6 cells (Figure 1B)
cultured at high glucose palmitate oxidation was low-
ered by about 30% compared to islets and cells cultured
at low glucose. In human islets reduced oxidation of the
fatty acid in the presence of high glucose compared to
low glucose was already detected after 3 hours. In INS-
1E cells exposed to palmitate for 24 or 48 hours oxida-
tion rate of the fatty acid was reduced by 80% in cells
cultured at high glucose compared to cells cultured at
low glucose (Figure 1C). After 3 hours, palmitate oxida-
tion in INS-1E cells cultured at low and high glucose
was similar. Addition of AICAR partially restored the
glucose-dependent reduction in palmitate oxidation in
INS-1E cells (Figure 1C) but not in human islets and
MIN6 cells (Figures 1A and 1B). When etomoxir was
added palmitate oxidation was reduced in both cell lines
and islets (Figure 1).
Palmitate-induced UPR is not affected by high glucose in
human islets, MIN6 cells or INS-1E cells
Translational attenuation is an early event of the UPR
and is achieved via the phosphorylation of PERK and
eIF2a [29]. In human islets and MIN6 cells exposed to
palmitate levels of p-eIF2a rose approximately 2-fold
after 3 hours and continued to rise in MIN6 cells (P <
0.05) but not in islets up to 48 hours (Figures 2A and 3A;
additional files 1A and 1B). Levels of p-eIF2a levels in
human islets and MIN6 cells exposed to palmitate were
neither changed by altering the glucose concentration
nor by adding AICAR or etomoxir. If ER stress is not
alleviated, activation of the PERK pathway leads to up-
regulation of pro-apoptotic protein CHOP [30]. When
protein levels of CHOP were measured in human islets
and MIN6 cells, no alterations were observed after 3
hours (Figures 2B and 3B; additional files 1A and 1B).
After 24 and 48 hours, palmitate caused 2-3 fold induc-
tion in the expression level of CHOP, however. The
induction was neither dependent on glucose nor eto-
moxir or AICAR concentrations. Potential activation of
IRE1 and ATF6 signaling was examined by measuring
expression level of BiP in human islets and MIN6 cells
exposed to palmitate. Levels of the chaperone were not
altered irrespective of culture time, glucose, AICAR or
etomoxir concentrations (Figures 2C and 3C; additional
files 1A and 1B).
Difference in palmitate oxidation observed at low
and high glucose was especially marked in INS-1E cells
(Figure 1A). UPR in INS-1E cells was therefore studied
more thoroughly. When phosphorylation levels of
eIF2a were measured in INS-1E cells cultured in the
presence of palmitate, p-eIF2a levels rose approxi-
mately 5-fold already after 3 hours and remained ele-
vated after 24 and 48 hours (Figure 4B; additional file
1C). The degree of palmitate-induced phosphorylation
of eIF2a was neither affected by the glucose concen-
tration, nor inclusion of AICAR or etomoxir, however.
The lack of glucose-dependency made us also measure
phosphorylation levels of PERK, the kinase responsible
for phosphorylation of eIF2a [14]. Phosphorylation
patterns of PERK were almost identical to those
observed of p-eIF2a (Figure 4A; additional file 1C).
Translation of transcription factor ATF4 is controlled
by p-eIF2a. When transcript level of ATF4 was mea-
sured, no significant changes were observed after 3
hours. After 24 and 48 hours, palmitate caused 3-fold
induction in the expression level of ATF4 (Figure 4C).
Again, these alterations were independent on glucose
concentration or addition of AICAR or etomoxir.
CHOP is a downstream target of ATF4. It has pro-
apoptotic properties and regulates expression of
another apoptotic factor, GADD34 [31]. Expression
level of CHOP transcript (not shown) and protein
(Figure 4D; additional file 1C) as well as GADD34
transcript (Figure 4E) were very similar to that of
ATF4. When IRE1 and ATF6 signaling were examined
in INS-1E cells exposed to palmitate, no significant
alterations in the expression level of pathway markers,
sXBP1 (Figure 4F), EDEM (Figure 4G) and BiP (Figure
4H; additional file 1C), were observed irrespective of
time, glucose, AICAR or etomoxir concentrations.
Table 1 Primers used for real-time PCR





Spliced XBP1 rat 5’-GAGTCCGCAGCAGGTG-3’ 5’-GCGTCAGAATCCATGGGA -3’
EDEM 5’ -CAGTCAAGTTAGTGATCAACAC- 3’ 5’ - TGTCATGTCACCAAAGGGCTG - 3’
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When markers of the UPR were compared with pal-
mitate oxidation in INS-1E cells, MIN6 cells or human
islets, no correlation was observed.
Discussion
ER stress and activation of UPR has been suggested as a
mechanism of how raised nutrient levels exert their
detrimental effects on palmitate-treated beta-cells.
Support for a role of ER stress in lipotoxicity via activa-
tion of the UPR has been supplied by studies, where
manifestations of the UPR were recorded in beta-cells
undergoing apoptosis as a consequence of exposure to
palmitate [4-7,9,10]. In triggering ER stress saturated
fatty acids such as palmiate are much more potent than
unsaturated fatty acids, such as oleate [32]. In line with
Figure 1 Palmitate oxidation in palmitate-exposed human islets
(A), MIN6 cells (B) and INS-1E cells (C). The cells and islets were
cultured for 3, 24 and 48 hours in the presence of 0.5 mM palmitate
(Pa) and 2 μCi [3H]palmitate per ml at 5.5 or 25 mM glucose (Glu).
AICAR (1 mM; Aic) or etomoxir (0.2 mM; Et) were added as indicated.
Islets cultured at 5.5 mM glucose; MIN6 cells cultured at 25 mM glucose
and INS-1E cells cultured at 11 mM glucose alone were considered as
controls. After culture, media were collected, 3H2O separated and
radioactivity determined by a liquid-scintillation spectrometer. Results
are means ± SEM of 3-4 independent experiments. *P < 0.05 compared
to low glucose and #p < 0.05 effect of additive.
Figure 2 Unfolded protein response in palmitate-exposed
human islets. The islets were cultured for 3, 24 or 48 hours in the
presence of 0.5 mM palmitate (Pa) at 5.5 or 25 mM glucose (Glu).
AICAR (1 mM, Aic) or etomoxir (0.2 mM, Et) were added as
indicated. Islets cultured at 5.5 mM glucose alone were considered
as control. After culture, protein levels of p-eIF2a (A), CHOP (B) and
BiP (C) were measured. Protein levels are means ± SEM of 4
independent experiments.*P < 0.05 compared to control.
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this, knocking-down SCD1 in palmitate-treated beta-
cells aggravates the toxic effect of the saturated fatty
acid [33].
The mechanisms of how fatty acids induce ER stress
are yet unclear. Some authors hypothesize that pro-
longed exposure to palmitate causes ER Ca2+ release,
which disturbs ER homeostasis and causes ER stress
[24,34]. However, it is unlikely that the observed modest
depletion of ER Ca2+ may lead to ER stress [4]. Another
argument against this hypothesis is that release of ER
Ca2+ was observed in cells treated with oleate, which
does not induce ER stress [24,34]. ER protein overload
is another mechanism, which may contribute to ER
stress in lipotoxic beta-cells. Recent studies showed that
protein overload might be a consequence of reduced
ER-to-Golgi protein trafficking or degradation of car-
boxypeptidase E [35,36]. However, absence of significant
changes in the expression level of molecular chaperones,
such as BiP, in the current and previous studies makes
this hypothesis questionable [4,10,11]. Up-regulation of
ER chaperones is a major response to accumulation of
unfolded protein in the ER. The protective role of BiP is
also questioned in the study, where over-expression of
BiP in INS-1 cells and MIN6 cells partially reduced sus-
ceptibility to thapsigargin but failed to reduce palmitate-
induced ER stress [6]. Furthermore, gene expression
analysis did not detect changes in mRNA level of ER
chaperones in palmitate-treated beta-cells [37]. It should
also be mentioned that in some studies results concern-
ing expression and role of BiP in palmitate-treated beta-
cells are opposite. Thus, Kharroubi et al. demonstrated
palmitate-induced up-regulation of BiP mRNA level
connected with enhanced apoptosis [5]. Also, Laybutt et
al. observed protective, ER stress-reducing and anti-
apoptotic effects of BiP over-expression [7].
Prolonged exposure to palmitate leads to formation of
tripalmitin [18]. It was shown that tripalmitin accumu-
lates in the ER rather than in the cytoplasm of the beta-
cells. This is in contrast to oleate, which forms droplets
in the cytoplasm [18]. Accumulation of insoluble tripal-
mitin may cause morphological perturbations in the ER
and be toxic for the beta-cells [17,18]. We hypothesized
that reducing fatty acid oxidation would accentuate ER
stress by increasing generation and incorporation of tri-
palmitin into microsomes. To reduce metabolism we
raised glucose, which inhibits palmitate oxidation and
shuttles the fatty acid to non-oxidative pathways [20,23].
Also, we used AMPK activator AICAR that stimulates,
and CPT1 inhibitor etomoxir that inhibits oxidation
[19,22,23]. Fatty acid oxidation was higher at low glu-
cose compared to high glucose concentration both in
cell lines and human islets, but especially pronounced in
INS-1E cells. Accentuated glucose-induced reduction in
palmitate oxidation in INS cells was also observed in
previous studies [23,38]. More efficient oxidation of
fatty acids by MIN6 cells and human islets compared to
INS-1E cells in the presence of high glucose might be
explained by higher activity of ACC in INS-1E cells [23].
The accentuated glucose-induced reduction in palmitate
oxidation in INS-1E cells may explain the significant
effect of AICAR in these cells. Surprisingly, essentially
similar activation of UPR by palmitate was observed
Figure 3 Unfolded protein response in palmitate-exposed
MIN6 cells. The cells were cultured for 3, 24 and 48 hours in the
presence of 0.5 mM palmitate (Pa) at 5.5 or 25 mM glucose (Glu).
AICAR (1 mM, Aic) or etomoxir (0.2 mM, Et) were added as
indicated. Cells cultured at 25 mM glucose alone were considered
as control. After culture, protein levels of p-eIF2a (A), CHOP (B) and
BiP (C) were measured. Protein levels are means ± SEM of 4
independent experiments. *P < 0.05 compared to control.
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Figure 4 Unfolded protein response in palmitate-exposed INS-1E cells. The cells were cultured for 3, 24 or 48 hours in the presence of 0.5
mM palmitate (Pa) at 5.5 or 25 mM glucose (Glu). AICAR (1 mM, Aic) or etomoxir (0.2 mM, Et) were added as indicated. Cells cultured at 11 mM
glucose alone were considered as control. After culture, protein levels of p-PERK (A), p-eIF2a (B), CHOP (D), BiP (H) and transcript levels of ATF4
(C), GADD34 (E), sXBP1 (F) and EDEM (G) were measured. Protein and transcripts levels are means ± SEM of 6 independent experiments. *P <
0.05 compared to control.
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both at low and high glucose concentrations. Further-
more, stimulation and inhibition of palmitate oxidation
by AICAR and etomoxir did not affect palmitate-
induced UPR activation. This holds true for both cell
lines and human islets. More robust activation of UPR
markers in INS-1E cells may speak in favor of higher
sensitivity of these cells to palmitate exposure.
Previous data on the role of glucose and fatty acid
metabolism in palmitate-induced ER stress response are
controversial. While Bachar et al claimed that glucose
amplified ER stress [39], Cunha et al showed that glucose
did not amplify ER stress in palmitate-treated beta-cells
[24]. The discrepancy was suggested to be explained by
the fact that protein and mRNA levels of ER stress mar-
kers were analyzed by the respective groups. Inhibition of
CPT1 by siRNA approach performed by Choi et al
caused increased expression of CHOP but decreased
phosphorylation of eIF2a and JNK [40].
Conclusions
Our finding suggests that factors other than palmitate
oxidation play major role in the palmitate-induced acti-
vation of UPR. Furthermore, the fact that apoptosis in
beta-cells depends on the oxidation of palmitate sug-
gests that the UPR is not a major mechanism by which
the fatty acid negatively affects the beta-cell. The
mechanisms by which palmitate activates UPR and its
role in the induction of apoptosis requires additional
studies.
Additional material
Additional file 1: Representatives gels of WB in human islets (A),
MIN6 cells (B) and INS-1E cells (C). The cells and islets were cultured
for 3 and 48 hours in the presence of 0.5 mM palmitate (Pa) at 5.5 or 25
mM glucose (Glu). AICAR (1 mM; Aic) or etomoxir (0.2 mM; Et) were
added as indicated. Islets cultured at 5.5 mM glucose, MIN6 cells cultured
at 25 mM glucose and INS-1E cells cultured at 11 mM glucose alone
were considered as controls. After culture, proteins were isolated and
subjected to immunoblot analyses with antibodies towards p-PERK (C),
p-eIF2a (A; B; C), CHOP (A; B; C) and BiP (A; B; C).
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